Register
Login:
Share:
Email Facebook Twitter


EXCLUSIVE: David Lenigas answers investor questions in a detailed interview about UKOG, Doriemus, LGC Capital, AfriAg and Angus Energy.


Astrazeneca Regulatory News (AZN)



Regulatory News for Astrazeneca (AZN)


Share Price: 5,162.00Bid: 5,162.00Ask: 5,165.00Change: 0.00 (0.00%)No Movement on Astrazeneca
Spread: 3.00Spread as %: 0.06%Open: 5,182.00High: 5,199.00Low: 5,159.00Yesterday’s Close: 5,162.00





DateSourceHeadlineCategory
18-Oct-17 07:00RNSFDA Priority Review for Lynparza in breast cancerCompany Announcement - General
17-Oct-17 07:00RNSFDA accepts sBLA file for Imfinzi; priority reviewCompany Announcement - General
09-Oct-17 07:00RNSFDA grants Tagrisso BTD for 1st-line EGFR nsclcCompany Announcement - General
02-Oct-17 15:00RNSTotal Voting RightsHolding(s) in Company
26-Sep-17 12:00RNSDirector/PDMR ShareholdingDirectors' Dealings
14-Sep-17 07:00RNSAspen acquires remaining rights to AZ anaestheticsCompany Announcement - General
11-Sep-17 07:00RNSTagrisso potential standard of care in lung cancerCompany Announcement - General
11-Sep-17 07:00RNSIMFINZI superior PFS in Stage III lung cancerCompany Announcement - General
07-Sep-17 12:39RNSCelgene and AZ update on Fusion trial programmeCompany Announcement - General
07-Sep-17 07:00RNSAZ Duaklir improves lung function in COPD patientsCompany Announcement - General
07-Sep-17 07:00RNSAZ tezepelumab cuts exacerbations in severe asthmaCompany Announcement - General
05-Sep-17 07:00RNSDirectorate ChangeExecutive Changes
01-Sep-17 15:00RNSTotal Voting RightsHolding(s) in Company
29-Aug-17 07:00RNSFaslodex gets US FDA OK for expanded use in breastCompany Announcement - General
18-Aug-17 07:00RNSLynparza gets broad FDA approval in ovarian cancerCompany Announcement - General
16-Aug-17 07:00RNSDirectorate ChangeExecutive Changes
14-Aug-17 16:30RNSHolding(s) in CompanyHolding(s) in Company
10-Aug-17 13:30RNSPublication of a ProspectusCompany Announcement - General
02-Aug-17 07:00RNSAZ acalabrutinib submission accepted by US FDACompany Announcement - General
01-Aug-17 15:00RNSTotal Voting RightsHolding(s) in Company
01-Aug-17 07:00RNSBTD for AZ's acalabrutinib in mantle cell lymphomaCompany Announcement - General
31-Jul-17 07:00RNSImfinzi granted BTD by US FDA for Stage III nsclcCompany Announcement - General
28-Jul-17 11:00RNSDirector/PDMR ShareholdingDirectors' Dealings
27-Jul-17 07:15RNSTagrisso significantly improves FLAURACompany Announcement - General
27-Jul-17 07:06RNSAZ & MERCK ESTABLISH STRATEGIC ONCOLOGY DEALCompany Announcement - General
27-Jul-17 07:00RNSAstraZeneca PLC - H1 2017 ResultsResults and Trading Reports
26-Jul-17 16:46RNSFaslodex receives EU approval for 1L breast cancerCompany Announcement - General
21-Jul-17 15:45RNSHolding(s) in CompanyHolding(s) in Company
03-Jul-17 14:59RNSTotal Voting RightsHolding(s) in Company
03-Jul-17 07:00RNSAZ COMPLETES SELOKEN AGREEMENT WITH RECORDATICompany Announcement - General


Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.